Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eisai
Pharma
Eisai, Sumitomo, Kyowa Kirin and more—Fierce Pharma Asia
Eisai presented updated projections for Leqembi. Sumitomo plans to lay off 400 U.S. staffers. Plus more.
Angus Liu
Mar 8, 2024 9:42am
Amid launch hurdles, Eisai updates Leqembi's sales forecast
Mar 7, 2024 11:29am
Eisai's Leqembi launch tripped up on a host of challenges
Feb 27, 2024 9:20am
Leqembi, Takeda, Roche—Fierce Pharma Asia
Feb 9, 2024 9:02am
Eisai's Leqembi rollout moves slower than expected
Feb 7, 2024 10:05am
'The Top Line': A closer look at new drug approvals in 2023
Jan 19, 2024 6:00am